Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets
Diksha Kumari, S.K. Mahajan, Parampreet Kour, et al.
Life Sciences (2022) Vol. 306, pp. 120829-120829
Closed Access | Times Cited: 23

Showing 23 citing articles:

Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses
Maritsa Margaroni, Maria Agallou, Evgenia Tsanaktsidou, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 304-304
Open Access | Times Cited: 14
Design, synthesis, and biological evaluation of eugenol-isoxazoline hybrid derivatives as potential anti-leishmanial agents
Dixhya Rani, Diksha Kumari, Anil Bhushan, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138105-138105
Closed Access | Times Cited: 4
Anhydroparthenin as a dual-target inhibitor against Sterol C-24 methyltransferase and Sterol 14-α demethylase of Leishmania donovani: A comprehensive in vitro and in silico study
Diksha Kumari, Parampreet Kour, Chetan Paul Singh, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 132034-132034
Closed Access | Times Cited: 4
Impact of Marasmic Malnutrition on Visceral Leishmaniasis: Progression and Treatment Efficacy in a Murine Model
Taiana Ferreira-Paes, Luiza F. O. Gervazoni, Paula Seixas-Costa, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 849-849
Open Access
Insights into the drug screening approaches in leishmaniasis
Boobalan Gopu, Parampreet Kour, Ramajayan Pandian, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109591-109591
Closed Access | Times Cited: 16
Microbial Matryoshka: Addressing the Relationship between Pathogenic Flagellated Protozoans and Their RNA Viral Endosymbionts (Family Totiviridae)
Alexandra Ibáñez‐Escribano, María Teresa Gómez-Muñoz, Marta Mateo, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 7, pp. 321-321
Open Access | Times Cited: 3
Repurposing FDA Approved Drugs against Sterol C-24 methyltransferase of Leishmania donovani: A Dual in silico and in vitro Approach
Diksha Kumari, Vishwani Jamwal, Ajeet Singh, et al.
Acta Tropica (2024) Vol. 258, pp. 107338-107338
Closed Access | Times Cited: 3
Design, synthesis, and biological evaluation of 3,3′-diindolylmethane N-linked glycoconjugate as a leishmanial topoisomerase IB inhibitor with reduced cytotoxicity
Parampreet Kour, Pallavi Saha, S.K. Bhattacharya, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 10, pp. 2100-2114
Open Access | Times Cited: 7
Multi-epitope vaccine design against leishmaniasis using IFN-γ inducing epitopes from immunodominant gp46 and gp63 proteins
Amir Ahmad Dehghani, Mina Mamizadeh, Atena Karimi, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 1, pp. 100355-100355
Open Access | Times Cited: 2
Hijacking the intrinsic vitamin B12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity
Aakriti Singh, Ganesh Yadagiri, Aaqib Javaid, et al.
Biomaterials Science (2022) Vol. 10, Iss. 19, pp. 5669-5688
Closed Access | Times Cited: 8
Distinct neutrophil effector functions in response to different isolates of Leishmania aethiopica
Emebet Adem, Edward Cruz Cervera, Endalew Yizengaw, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Design and evaluation of a novel multi-epitope antigen for evaluate the diagnostic immunity responses against Leishmania infantum infection
Pejman Hashemzadeh, Mojgan Bandehpour, Farnaz Kheirandish, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Genome alteration of Leishmania orientalis under Amphotericin B inhibiting conditions
Pornchai Anuntasomboon, Suradej Siripattanapipong, Sasimanas Unajak, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 12, pp. e0012716-e0012716
Open Access | Times Cited: 1
Generation of Aurachin Derivatives by Whole-Cell Biotransformation and Evaluation of Their Antiprotozoal Properties
Sebastian Kruth, Cindy J.-M. Zimmermann, Katharina Kuhr, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1066-1066
Open Access | Times Cited: 3
DNA topoisomerases as a drug target in Leishmaniasis: Structural and mechanistic insights
Parampreet Kour, Pallavi Saha, Deepak K. Sharma, et al.
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128401-128401
Closed Access | Times Cited: 3
Investigating the Leishmania donovani sacp Gene and Its Role in Macrophage Infection and Survival in Mice
Kayla Paulini, Patrick Lypaczewski, Wen‐Wei Zhang, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 11, pp. 384-384
Open Access | Times Cited: 4
Immunoinformatic Analysis of Leishmania Major gp46 Protein and Potential Targets for Vaccination against Leishmaniasis
Mohammad Reza Hafezi Ahmadi, Mina Mamizadeh, Davood Siamian, et al.
Recent Advances in Inflammation & Allergy Drug Discovery (2024) Vol. 18, Iss. 2, pp. 129-139
Closed Access
Leishmaniinae: Evolutionary inferences based on protein expression profiles (PhyloQuant) congruent with phylogenetic relationships among Leishmania, Endotrypanum, Porcisia, Zelonia, Crithidia, and Leptomonas
Simon Ngao Mule, Evaristo Villalba Alemán, Lívia Rosa-Fernandes, et al.
PROTEOMICS (2024)
Closed Access
Multi-target Compounds against Trypanosomatid Parasites and Mycobacterium tuberculosis
M. C. De O. Gomes, Emanuelly Karla Araújo Padilha, Gustavo Rafael Angelo Diniz, et al.
Current Drug Targets (2024) Vol. 25, Iss. 9, pp. 602-619
Closed Access
Distinct neutrophil effector functions in response to different isolates of Leishmania aethiopica
Emebet Adem, Edward Cruz Cervera, Endalew Yizengaw, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access
Harnessing computational and experimental approaches to identify potent hits against Leishmania donovani sterol C-24 methyltransferase from ChemBridge library
Diksha Kumari, Tashi Palmo, Somdutt Mujwar, et al.
Acta Tropica (2024) Vol. 260, pp. 107473-107473
Closed Access
Biomarker Studies of Glycoproteins and Mass Spectrometry
Muhammad Aquib, Tarnnum Quadri, Kuljit Singh, et al.
(2024), pp. 103-120
Closed Access
Leishmaniinae: evolutionary inferences based on protein expression profiles (PhyloQuant) congruent with phylogenetic relationships amongLeishmania, Endotrypanum, Porcisia, Zelonia, Crithidia,andLeptomonas
Simon Ngao Mule, Evaristo Villalba Alemán, Lívia Rosa-Fernandes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top